Medication overuse headache - An under-diagnosed problem in shunted idiopathic intracranial hypertension patients

British Journal of Neurosurgery

Volumn 29, Issue 1, 2015, Pages 30-34

  DeSouza, Ruth Mary ^a   Toma, Ahmed ^a   Watkins, Laurence ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Headache; Idiopathic intracranial hypertension; Medication; Overuse; Shunt

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ANALGESIA; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID SHUNTING; CLINICAL ARTICLE; DECOMPRESSION SURGERY; DRUG INDUCED HEADACHE; FEMALE; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; LENGTH OF STAY; LUMBOPERITONEAL SHUNT; MIGRAINE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; SHUNT INFECTION;

EID: 84929315199     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.3109/02688697.2014.950633     Document Type: Article

References (16)

1. Willer L, Jensen RH, Juhler M. Medication overuse as a cause of chronic headache in shunted hydrocephalus patients. J Neurol Neurosurg Psychiatry 2010;81:1261-4.
2. Colás R, Muñoz P, Temprano R, Gómez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004;62:1338-42.
3. De Felice M, Ossipov MH, Porreca F. Update on medicationoveruse headache. Curr Pain Headache Rep 2011;15:79-83. [Review].
4. De Felice M, Porreca F. Opiate-induced persistent pro-nociceptive trigeminal neural adaptations: potential relevance to opiate-induced medication overuse headache. Cephalalgia 2009; 29: 1277-84.
5. Saper JR. Chronic headache syndromes. Neurol Clin 1989;7:387-412. [Review].
6. Starling AJ, Hoffman-Snyder C, Halker RB, et al. Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topic. Neurologist 2011; 17: 297-9. [Review].
7. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd ed. Cephalalgia 33:629-808. http://www.ihs-classification.org/-downloads/mixed/International-Headache-Classification-III-ICHD-III-2013-Beta.pdf
8. Evers S, Jensen R;European Federation of Neurological Societies. Treatment of medication overuse headache - guideline of the EFNS headache panel. Eur J Neurol 2011;18:1115-21.
9. Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: The Eurolight project. Eur J Neurol 2012;19:703-11.
10. Göbel H, Heinze A. Chronic migraine and headache by medication overuse. Evolution and revision of classification. Schmerz 2011;25:493-500.
11. Negro A, Martelletti P. Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain 2011;12:593-601.
12. Friedman DI, Rausch EA. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology 2002;58:1551-3.
13. De Simone R, Ranieri A, Fiorillo C, Bilo L, Bonavita V. Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression. Neurol Sci 2010; 31: 411-5. [Review].
14. Mathew NT, Ravishankar K, Sanin LC. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 1996;46:1226-30.
15. Vieira DS, Masruha MR, Gonçalves AL, et al. Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine. Cephalalgia 2008;28:609-13.
16. Rainero I, Ferrero M, Rubino E, et al. Endocrine function is altered in chronic migraine patients with medication-overuse. Headache 2006;46:597-603.